Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | F3 | P13726 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11587157 | 1.00 | MAPT (0.63) | MAPTKMT2AALDH1A1F3RAB9A | |
| SCHEMBL10694907 | 0.82 | ALDH1A1 (0.52) | MAPTKMT2AALDH1A1F3RAB9A | |
| SCHEMBL13519185 | 0.82 | ALDH1A1 (0.78) | MAPTKMT2AALDH1A1RAB9AMAOB | |
| SCHEMBL11818123 | 0.82 | ALDH1A1 (0.78) | MAPTKMT2AALDH1A1RAB9AMAOB | |
| SCHEMBL11818127 | 0.82 | ALDH1A1 (0.78) | MAPTKMT2AALDH1A1RAB9AMAOB | |
| SCHEMBL26976333 | 0.82 | ALDH1A1 (0.52) | MAPTKMT2AALDH1A1F3RAB9A | |
| SCHEMBL10694911 | 0.82 | ALDH1A1 (0.52) | MAPTKMT2AALDH1A1F3RAB9A | |
| SCHEMBL956091 | 0.80 | CYP1A2 (0.63) | MAPTKMT2AALDH1A1RAB9AMAOB | |
| SCHEMBL13960902 | 0.80 | MAPT (0.63) | MAPTKMT2AALDH1A1RAB9AMAOB | |
| SCHEMBL22797129 | 0.80 | ALDH1A1 (0.50) | MAPTKMT2AALDH1A1F3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115120722-A | Use of SP/KLF transcription factor inhibitors | 天津医科大学 | 2022-09-30 | — | — | CN | claimed |
| CN-115120722-B | Use of SP/KLF transcription factor inhibitors | 天津医科大学 | 2024-02-09 | — | — | CN | disclosed |
| CN-111759827-B | A pharmaceutical composition for preventing or treating arthritis or inflammatory diseases | 忠北大学校产学协力团 | 2023-02-07 | — | — | CN | disclosed |
| CN-115120722-A | Use of SP/KLF transcription factor inhibitors | 天津医科大学 | 2022-09-30 | — | — | CN | disclosed |
| CN-113214114-A | Reactive group-blocked diisocyanate for 3D object printing, composition, and method and apparatus for printing 3D object | 珠海赛纳三维科技有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-107438433-B | Pharmaceutical composition for preventing and treating arthritis or inflammatory diseases containing 2-methoxy-4- (3- (4-methoxyphenyl) prop-1-en-1-yl) phenol as an active ingredient | 忠北大学校产学协力团 | 2021-06-25 | — | — | CN | disclosed |
| CN-107090414-B | Pesticidal flavobacterium strains | 马罗内生物创新公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-111759827-A | A pharmaceutical composition for preventing or treating arthritis or inflammatory diseases | 忠北大学校产学协力团 | 2020-10-13 | — | — | CN | disclosed |
| US-7067074-B2 | Near-infrared-absorbing composition and optical material | KUREHA CORPORATION (JP) | 2006-06-27 | — | — | US | disclosed |
| US-7053231-B2 | Building material | KUREHA CHEMICAL INDUSTRY COMPANY, LTD. (JP) | 2006-05-30 | — | — | US | disclosed |
| US-20040204600-A1 | Building Material | KUREHA CHEMICAL INDUSTRY COMPANY, LIMITED | 2004-10-14 | — | — | US | disclosed |
| US-6803367-B2 | ANTICANCER AGENTS; SYNERGISTIC MIXTURES | TAKARA SHUZO CO., LTD. (JP) | 2004-10-12 | — | — | US | disclosed |
| EP-1447687-A1 | BUILDING MATERIAL | Kureha Chemical Industry Co., Ltd. (JP) | 2004-08-18 | — | — | EP | disclosed |
| US-20030160217-A1 | Near-infrared-absorbing composition and optical material | KUREHA CORPORATION (JP) | 2003-08-28 | — | — | US | disclosed |
| US-20030065014-A1 | Substance for inducing apoptosis | TAKARA BIO INC. (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-1277821-A1 | NEAR-INFRARED-ABSORBING COMPOSITION AND OPTICAL MATERIAL | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2003-01-22 | — | — | EP | disclosed |
| US-4734471-A | Method of curing polyfluoroalkoxyphosphazene | ETHYL CORPORATION (US) | 1988-03-29 | — | — | US | disclosed |
| US-4389236-A | POSTEMERGENCE | CIBA-GEIGY CORPORATION (US) | 1983-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065014-A1 | Substance for inducing apoptosis | BAX, BCL2, BAD | MAPT 3068/4885KMT2A 4360/4885ALDH1A1 1247/4885 |
| US-20040204600-A1 | Building Material | PRPF8, COPS8, COG8 | MAPT 631/4885KMT2A 1814/4885ALDH1A1 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.